have evaluated the effects of YM175 {disodium dihydrogen (cycloheptylamino) methylenebisphosphonate monohydrate}, a novel bisphosphonate, on bone mineral densities (BMD) at the lumbar spine and forelimb in ovariectomized beagles with dietary calcium restriction. Groups 1 and 2 were given a sham operation and Groups 3 6 were ovariectomized. One month later (month 0), a low calcium diet was given to Groups 2-6. Groups 4-6 were orally treated with YM175 at doses of 0.01, 0.1 and 1.0 mg/kg, respectively, for 18 months. Changes in BMD at the lumbar spine and left forelimb were determined serially by dual energy X-ray absorptiometry. Calcium restriction decreased lumbar BMD by 19% at month 2 and by up to 30% at month 17 compared to its baseline value, but ovariectomy itself had a minimal effect on bone mass in dogs with restricted calcium intake. YM175 (1 mg/kg) prevented the bone loss at month 2 and YM 175 at 0.1 mg/kg or more inhibited the BMD reduction at month 17. The magnitude of BMD reduction of the forelimb was less remarkable as compared to that of the lumbar spine. Urinary hydroxy proline excretion and plasma osteocalcin levels were increased by calcium restriction, indicating a high turnover of bone. YM 175 reduced hydroxyproline excretion but not osteocalcin levels. These results indicate that YM 175 prevents bone loss induced by calcium restriction and ovariectomy through partially normalizing high bone turnover.
ABSTRACT-We
have evaluated the effects of YM175 {disodium dihydrogen (cycloheptylamino) methylenebisphosphonate monohydrate}, a novel bisphosphonate, on bone mineral densities (BMD) at the lumbar spine and forelimb in ovariectomized beagles with dietary calcium restriction. Groups 1 and 2 were given a sham operation and Groups 3 6 were ovariectomized. One month later (month 0), a low calcium diet was given to Groups 2-6. Groups 4-6 were orally treated with YM175 at doses of 0.01, 0.1 and 1.0 mg/kg, respectively, for 18 months. Changes in BMD at the lumbar spine and left forelimb were determined serially by dual energy X-ray absorptiometry. Calcium restriction decreased lumbar BMD by 19% at month 2 and by up to 30% at month 17 compared to its baseline value, but ovariectomy itself had a minimal effect on bone mass in dogs with restricted calcium intake. YM175 (1 mg/kg) prevented the bone loss at month 2 and YM 175 at 0.1 mg/kg or more inhibited the BMD reduction at month 17. The magnitude of BMD reduction of the forelimb was less remarkable as compared to that of the lumbar spine. Urinary hydroxy proline excretion and plasma osteocalcin levels were increased by calcium restriction, indicating a high turnover of bone. YM 175 reduced hydroxyproline excretion but not osteocalcin levels. These results indicate that YM 175 prevents bone loss induced by calcium restriction and ovariectomy through partially normalizing high bone turnover. Keywords Cessation of ovarian function is a major cause of the development of postmenopausal osteoporosis (1, 2). Ovariectomized rats have been used extensively as a model for osteoporosis.
In this animal model, the trabecular bone mass decreases significantly within sev eral weeks (3 5). For this reason, it is appropriate to evaluate the efficacy of pharmacological agents on bone loss associated with estrogen deficiency in this model. However, the skeletal metabolism of rats is quite different from that of the adult humans because rat bone grows throughout their life period (6). Therefore, the informa tion obtained from this model can not be directly extra polated to the pathogenesis of human osteoporosis. It is necessary to develop a different animal model that exhibits human-like remodeling dynamics. The potential utility of ovariectomized dogs as a model of postmeno pausal bone loss has been examined by several investi gators (7 -12) but the effects of ovariectomy on bone mass in dogs remain controversial. Some could detect significant bone loss (7-10), but others could not (11, 12) . One possible explanation for the differing response of canine skeleton to estrogen deficiency would be attributed to the high calcium content in commercially available dog chow (13), as it has been reported that low dietary calcium increases the sensitivity to ovarian hormone deficiency in rats (14, 15) and minipigs (16). Thus, it is suggested that ovariectomized dogs with calcium restriction would be suitable for studying problems that are relevant to postmenopausal bone loss.
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Bisphosphonates are analogues of pyrophosphates that contain P-C-P bonds, and they strongly bind to hydroxy apatite crystals and inhibit bone resorption (17, 18 Twelve dogs at the age of 21 months were given a sham operation and divided into 2 groups (Groups 1-2). The remaining 28 dogs were ovariectomized (month 1) and divided into 4 groups (Groups 3-6). One month after the surgery (month 0), the diet for Groups 2-6 was changed to a low calcium diet (calcium: 0.14%; Oriental Yeast, Tokyo), which contained 1/10 the calcium contained in the standard diet. YM175 was packed into gelatin cap sules and the volume was adjusted with lactose. The animals in Groups 4, 5 and 6 were orally given YM 175 at doses of 0.01, 0.1 and 1.0 mg/kg, respectively, for 18 months (5 days a week), while Groups 1 3 received cap sules containing lactose alone. Body weight was measured every two weeks. Tap water was given ad libitum and the amount of the food served was 300 g daily. The tempera ture in the room was maintained at 22±1V.
The ex perimental protocol was approved by the local animal ethics committee for animal studies.
Bone mineral density (BMD) measurement BMD (g/cm2) of the 2nd, 3rd and 4th lumbar vertebrae (L2-4) and left forelimb (radius and ulna) were measured by dual energy X-ray absorptiometry (DEXA) (XR-26; Norland Corporation, WI, USA) under xylazine-pento barbital anesthesia. The averaged bone mass for L2-4 or for the whole radius and ulna (including epiphysis, metaphysis and diaphysis) were obtained before ovari ectomy or sham operation and at 2, 5, 8, 11, 14 and 17 months following the start of calcium restriction. The final determination of BMD at the forelimb was conduct ed at month 18 instead of month 17. BMD of the lumbar spine or forelimb was also expressed as 010 of baseline BMD. The scan speed was set at 80 mm/sec. The point and line resolution was 1 x 1 mm for the lumbar spine or 1.5 x 1.5 mm for the forelimb, respectively. The coefficient of variation of five repeated scans conducted on the same preparation on the single day was 2.0010 for the lumbar spine or 1.5010 for the forelimb, respectively.
Plasma and urine chemistry
Blood samples were collected monthly with heparinized syringes. Plasma was separated by a brief centrifugation (1,800 x g for 10 min) and stored at 80C until analysis. Plasma concentrations of calcium, inorganic phospho rus, alkaline phosphatase, urea nitrogen and total protein were determined by colorimetric methods using an auto analyzer (model 736-10; Hitachi, Tokyo). The reagent kits used in this study were obtained from Daiichi Pure Chemicals (Tokyo). Plasma concentrations of 1,25-dihy droxyvitamin D {1,25-(OH)2D} and osteocalcin were de termined by radioreceptor assay and by radioimmunoas say (28), respectively (Teijin-Bio Laboratories, Tokyo). The amount of urinary hydroxyproline excreted for 24 hr was measured using the chloramine-T resin method (29). The hydroxyproline excretion was normalized for creati nine concentration (Creatinine test-Wako; Wako Pure Chemical Industries, Osaka).
Statistical analyses
Values are expressed as the mean ±S.E.M. Analysis of data from Groups 1 3 and Groups 3 6 were performed separately by two-way repeated measures analysis of variance (ANOVA) in order to examine the time-depend ent effects of calcium restriction, ovariectomy and YM175 on bone mass and the indices related to bone metabo lism. If the interaction between the time and each treatment shown above was confirmed statistically, multiple com parisons between Groups 1 3 or Groups 3 6 were per formed at the respective time intervals by Scheffe's test or Dunnet's multiple range test, respectively. A P value less than 0.05 was considered statistically significant.
RESULTS

General conditions
One dog in Group 4 died at (month 10). The rest of the dogs the
age of 31 months remained healthy until the end of the study. Consistent with the findings reported by others (7, 11), ovariectomized groups gained about 1.6-2.2 kg in body weight on the average during the study (data not shown). However, no weight gain was observed in Groups 1 and 2, showing that the standard or the low calcium diet had no effect on the body weight un der our conditions. treated with YM175 at doses of 0.1 and 1.0 mg/kg (Groups 5 and 6, respectively) were maintained at sig nificantly higher levels than those in Group 3 at month 8 and thereafter. As shown in Fig. 2 , YM 175 dose-depend ently prevented decreases in lumbar BMD at month 17, which were expressed as g/cm2.
Changes in BMD of forelimb Changes in BMD of lumbar spine Figure 1 shows the mean changes in lumbar BMD for each group with time, which are expressed as a percent of the baseline BMD before ovariectomy or sham operation. The baseline value of lumbar BMD (month 1) in Group 1 was 0.584±0.031 g/cm2, and this value was not sig nificantly different from those of other groups (data not shown). BMD of Group 1 did not change significantly throughout the experimental period. Group 2 at month 2 exhibited a 19% reduction in lumbar BMD and it grad ually decreased by up to 30010 at month 17. Groups 2 and 3 exhibited comparable reductions in lumbar BMD, in dicating that ovariectomy itself had a minimal effect in dogs fed the low calcium diet. Although there were no differences in lumbar BMD among Groups 3, 4 and 5 at month 2, BMD in Group 6 was significantly higher than that in Group 3, demonstrating that YM 175 at a dose of 1.0 mg/kg partially but significantly prevented bone loss at month 2. In contrast to the slow continuous reduction in BMD in Group 3 after month 2, BMD in the groups The extent of forelimb BMD reduction in Group 3 was less remarkable as compared with those seen at the lum bar spine (Fig. 3) . BMD in Group 3 was lower than that in Group 1 by 4.3010 at month 2 and by 14.7% at month 18. In addition, Group 2 showed almost the same extent of BMD loss as those seen in Group 3 except in months 11 and 14. In contrast to the effects of YM 175 on lumbar BMD reduction, YM 175 ameliorated the reduction in BMD at month 18, whereas this agent had no effect on BMD in Group 6 at month 2 (Figs. 3 and 4 ).
Plasma and urine chemistry
It seems likely that 1,25-(OH)2D levels in dogs fed a low calcium diet were increased according to an increase in the duration of the experiment (Fig. 5) . The concentra tions of 1,25-(OH)2D in Groups 2 and 3 were consistently higher than those in Group 1. Neither ovariectomy nor YM175 had significant effect on 1,25-(OH)2D levels. As shown in Table 1 , plasma alkaline phosphatase activity in Groups 2 and 3 were increased at month 2, but returned to (Table 2 ). YM175 at 1.0 mg/kg inhibited the elevation of hydroxyproline levels throughout the experimental period. Plasma concentrations of osteocalcin in Groups 2 and 3 were significantly higher than that in Group 1, but no difference was observed between the two groups. YM175 had no significant effect on osteocalcin levels (Table 3) . Table 2 . Urinary hydroxyproline excretion (pg/mg creatinine) Table 3 . Plasma osteocalcin levels (ng/ml)
DISCUSSION
The present study has demonstrated that dietary cal cium restriction caused a marked bone loss at the lumbar spine in sham-operated or ovariectomized beagle dogs within 2 months after the start of the calcium restriction (Figs. 1 and 2) . Lumbar BMD in sham-operated dogs (Group 2) was decreased by 19010 at month 2 compared to baseline BMD, and an additional 11010 of reduction was observed at month 17, leading to the total 30°10 reduction in lumbar BMD for 17 months. Ovariectomy itself may have a minimal effect on bone mass in dogs with restricted calcium intake because there was no statistically sig nificant difference in lumbar BMD reduction between the two groups, without or with ovariectomy (Groups 2 and 3 in Fig. 1 ). The reduction in BMD of the forelimb was less remarkable as compared with those of the lumbar spine (Figs. 3 and 4) . The BMD in Group 3 was lower than that in Group 1 by 4.3010 at month 2 and by 14.7010 at month 18. These data may suggest that the difference between the lumbar spine and forelimb regarding the time-course and the magnitude of bone loss was due to the different composition of each bone. It is well-established that the turnover rate of trabecular bone is more rapid than that of cortical bone (5, 30). Since we measured BMD of whole lumbar spine and left forelimb in this study, the relative ratio of trabecular and cortical bones in each bone might be one of the most important determinants for bone turnover rate. Thus, our result showed that bone loss of the lumbar spine was more rapid than that of forelimb, suggesting that the turnover rate in the lumbar spine was higher than that in the forelimb.
Several studies have examined effects of ovariectomy on histomorphometric changes in cancellous and cortical bones in dogs. Although ovariectomy resulted in a sig nificant bone loss in rats (3 5), the effects of ovariectomy on bone mass in dogs remain controversial (7-12). However, Nakamura and his associates (13, 31) reported the findings that ovariectomy resulted in the mechanical and histomorphological failure of the lumbar spine in dogs receiving a low calcium diet and then proposed the hypothesis that an excessive amount of calcium in the standard dog diets blunt the effect of ovariectomy in dogs. In our previous study (27), we have demonstrated that the sensitivity of bone to ovariectomy in dogs may not greatly increase 18 months after the restriction of cal cium intake. Although the contribution of ovariectomy to the reduction in bone mass and mechanical strength at the organ level was small in this model, the histomorpho metric examination identified that ovariectomy sig nificantly increased trabecular separation, which was not increased by calcium restriction alone, indicating that ovariectomy deteriorated trabecular bone structure in dogs. In the present study, we have intensively examined the time-dependent effects of ovariectomy and calcium restriction on bone mass by measuring BMD at the lum bar spine and forelimb serially until 18 months. The results indicated that the reduction in lumbar BMD ob served in this model was mainly caused by the calcium restriction. This is compatible with our previous bone mass and biomechanical study (27) .
As shown in Figs. 1 and 2 , YM 175 at a dose of 1.0 mg/kg partially but significantly prevented lumbar BMD loss at month 2. YM175 at doses of 0.1 and 1.0 mg/kg prevented lumbar BMD loss at month 8 and thereafter. The magnitude of BMD reduction of the forelimb in Group 3 was less remarkable as compared with those seen at the lumbar spine (Fig. 3) . YM 175 did not ameliorate BMD reduction at the forelimb throughout the treatment period except in month 18 (Fig. 4) . It is well-established that bisphosphonates are incorporated into bone rapidly and dose-dependently after the administration and that these agents showed a long half-life of skeletal retention (32). In addition, it is reported that bisphosphonates are distributed mainly on the resorption surface of bone It is reported that there is an adaptive response in increasing 1,25-(OH)2D production when the supply of dietary calcium was limited (33, 34). 1,25-(OH)2D levels in dogs fed a low calcium diet were increased according to the duration of the experiment (Fig. 5) . However, neither ovariectomy nor YM 175 had significant effects on 1,25 (OH)2D levels. The mechanism for the adaptive response in the production of 1,25-(OH)2D is unknown. There was no significant change in plasma levels of calcium be tween all groups throughout the study (Table 1) . However, plasma alkaline phosphatase activities in Groups 2 and 3 were increased at month 2, but gradually decreased at month 11. The low calcium diet caused a slight increase in urinary hydroxyproline excretion and also elevated plasma osteocalcin levels in these groups. These changes suggested that bone loss caused by a low calcium diet might to be attributable to the increased rate of bone turnover with resorption exceeding formation. YM 175 reduced the increase in urinary hydroxyproline excretion but did not change elevated levels of plasma alkaline phosphatase and osteocalcin, suggesting that this agent suppressed bone resorption without affecting bone formation. This is compatible with our recent findings showing that the mineral apposition rate and bone for mation rate were not greatly reduced by the treatment with YM175 as estimated by dynamic histomorphometry (27). 
